Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery

As part of a feasibility study, it's planned to use a 3D virtual mixed reality model with prostate cancer patients who show signs of lymph node metastasis and are scheduled for surgery. The model is based on PSMA PET imaging performed prior to surgery and will be evaluated by surgeons, the surgical team, and patients as part of the consultation process. First, the researcher investigates whether the removal of lymph node metastases has improved compared to the data in the literature . In addition, the study examines how the 3D model influences the movement of surgical instruments and the effic

Trial Details

NCT ID
NCT07129551
Phase
NA
Sponsor
Martini-Klinik am UKE GmbH
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • preop virtual 3D model
  • postop 3D model
Locations (sample)
  • Hamburg, Free and Hanseatic City of Hamburg, Germany|53.55073,9.99302
  • Hamburg, Free and Hanseatic City of Hamburg, Germany|53.55073,9.99302

Key Eligibility Criteria

  • Patients with hormone-sensitive prostate cancer scheduled for radical prostatectomy with pelvic lymph node dissection
  • \<3 PSMA-PET-avid lymph node metastases (PSMA expression score \>2) in the pelvis.
  • Patients with hormone-sensitive recurrent prostate cancer after radical prostatectomy with planned pelvic salvage lymph node dissection
  • \<3 PSMA-PET-avid lymph node metastases (PSMA expression score \>2) in the pelvis

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →